US approves Covid therapy, G20 pushes for global vaccine access

US drug regulators gave emergency approval to a Covid-19 antibody therapy on Saturday and G20 nations pushed for global access to vaccines as the pandemic led to further closures in parts of the world. But despite those developments, there are concerns that countries across the world will have insufficient access to vaccines, and G20 nations gathered for a virtual summit on Saturday highlighted those worries.